SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2014

Accounting Policies [Abstract]

Financial Instruments Where Carrying Value and Fair Value Differ

Fair Value of Financial Instruments
The following details our financial instruments where the carrying value and the fair value differ (amounts in millions):
			Fair Value at Reporting Date Using
Financial Instrument		Carrying Value as of June 30, 2014		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-term obligations	$	144.3	$	0	$	144.7	$	0

Weighted-Average Shares Outstanding

The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net income (loss) attributable to Amedisys, Inc. common stockholders (amounts in thousands):

		For the Three-Month Periods Ended June 30,		For the Six-Month Periods Ended June 30,
		2014	2013	2014	2013
Weighted average number of shares outstanding - basic		32,251	31,160	32,058	30,900
Effect of dilutive securities:
	Stock options	0	12	0	17
	Non-vested stock and stock units	343	317	0	381
Weighted average number of shares outstanding - diluted		32,594	31,489	32,058	31,298
Anti-dilutive securities		192	217	649	217